LONDON, England, July 16 -- Wellcome, a charitable foundation, posted the following news release:

* * *

Manufacturer agreed for the M72 TB vaccine candidate, pending trial outcomes

*

The sponsor of the late-stage clinical trial Gates Medical Research Institute (Gates MRI) has reached an agreement with the Serum Institute of India Private Limited (SII) to manufacture M72/AS01E, a novel tuberculosis vaccine candidate.

Currently in a . . .

Click here for more information about our products